The current status of adjuvant treatment for high-risk renal cell carcinoma

Future Oncol. 2017 Oct;13(23):2017-2020. doi: 10.2217/fon-2017-0352. Epub 2017 Oct 6.
No abstract available

Keywords: adjuvant treatment; renal cell carcinoma; tyrosine kinase inhibitors.

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / pathology*
  • Chemotherapy, Adjuvant
  • Clinical Trials, Phase III as Topic
  • Combined Modality Therapy
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology*
  • Neoplasm Grading
  • Neoplasm Staging
  • Protein Kinase Inhibitors / therapeutic use
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors